| Financial Year |
March 31 2023 |
| Monetary Funds |
11,265,437,170.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
163,327,501.42 |
| Accounts Receivable |
1,213,710,299.62 |
| Advances to Suppliers |
936,999,785.40 |
| Other Receivables |
135,795,942.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
783,985,994.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
287,009,551.99 |
| Total Current Assets |
14,991,793,160.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
68,048,632.00 |
| Long-term Equity Investment |
637,864,635.06 |
| Investment Properties |
172,425,414.34 |
| Fixed Assetes |
14,748,317,733.61 |
| Under-construction Projects |
5,070,274,647.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,916,667,772.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
596,762,290.35 |
| Deferred Income Tax Assets |
514,735,675.30 |
| Other Non-Current Assets |
3,106,732,307.40 |
| Sub-Total of Non-Current Assets |
31,235,087,045.80 |
| Total Assets |
46,226,880,206.20 |
| Short-Term Loans |
1,593,622,091.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,055,043.50 |
| Accounts Payable |
4,069,985,681.05 |
| Accounts Received In Advance |
195,168.65 |
| Employee Compensation Payable |
634,870,980.69 |
| Taxes Payable |
1,408,381,081.50 |
| Interest Payable |
17,545,594.44 |
| Dividend Payable |
2,084,132,265.18 |
| Other payables |
3,424,831,220.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,072,129,344.87 |
| Other Current Liabilities |
606,210,659.77 |
| Sub-Total of Current Liabilities |
17,876,205,270.26 |
| Long-term Loans |
3,707,042,679.37 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
241,421,945.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,407,653,831.54 |
| Deferred Income Tax Liabilities |
219,032,399.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,670,363,997.73 |
| Total Liabilities |
24,546,569,267.99 |
| Paid-In Capital(Or Share Stock) |
1,982,456,140.00 |
| Capital Surplus |
3,351,382,009.47 |
| Surplus Reserve |
991,228,070.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,823,039,366.66 |
| Minority Stockholder's Interest |
4,844,665,849.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,835,645,088.92 |
| Owner's Equity（Stockholder's Equity） |
21,680,310,938.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
46,226,880,206.20 |
